Autonomix Medical, Inc. is a medical device company focused on advancing technologies to develop how diseases involving the nervous system are diagnosed and treated. The Company’s first-in-class platform system technology includes a catheter-based microchip sensing array that may have the ability to detect and differentiate neural signals with greater sensitivity. It is developing its technology for pancreatic cancer and pancreatitis, conditions that can cause debilitating pain and need an effective solution. Its technology constitutes a platform to address dozens of potential indications, including cardiology, hypertension and chronic pain management, across a wide disease spectrum. Its development efforts are divided into two parts: diagnostic sensing and therapeutic radiofrequency ablation. The Company is developing Autonomix system, which is primarily catheter-based, meaning that its sensing equipment is delivered to its targeted location via a lumen within the body.
Símbolo de cotizaciónAMIX
Nombre de la empresaAutonomix Medical Inc
Fecha de salida a bolsaJan 29, 2024
Director ejecutivoHauser (Bradley)
Número de empleados8
Tipo de seguridadOrdinary Share
Fin del año fiscalJan 29
Dirección21 Waterway Ave, Suite 300
CiudadTHE WOODLANDS
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal77380
Teléfono18322777816
Sitio Webhttps://autonomix.com/
Símbolo de cotizaciónAMIX
Fecha de salida a bolsaJan 29, 2024
Director ejecutivoHauser (Bradley)
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.

Sin datos